CRIS Current Research Information System

LAURIOLA, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.030
NA - Nord America 4.677
EU - Europa 4.211
SA - Sud America 302
AF - Africa 264
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.595
IT - Italia 1.838
SG - Singapore 1.411
CN - Cina 1.329
VN - Vietnam 1.139
GB - Regno Unito 517
DE - Germania 420
HK - Hong Kong 304
SE - Svezia 297
BR - Brasile 238
FR - Francia 213
IN - India 174
KR - Corea 162
NL - Olanda 152
IE - Irlanda 142
RU - Federazione Russa 119
AT - Austria 111
FI - Finlandia 111
BD - Bangladesh 97
JP - Giappone 91
CI - Costa d'Avorio 89
ZA - Sudafrica 64
UA - Ucraina 57
TG - Togo 56
CA - Canada 53
ID - Indonesia 45
JO - Giordania 45
BG - Bulgaria 40
EE - Estonia 40
TH - Thailandia 35
CH - Svizzera 34
PH - Filippine 33
AR - Argentina 30
MY - Malesia 25
ES - Italia 24
PL - Polonia 22
SC - Seychelles 22
TW - Taiwan 18
AU - Australia 16
IL - Israele 16
IQ - Iraq 16
TR - Turchia 16
PK - Pakistan 15
GR - Grecia 14
IR - Iran 14
MX - Messico 13
DK - Danimarca 11
SA - Arabia Saudita 11
EC - Ecuador 10
RO - Romania 9
UZ - Uzbekistan 9
MA - Marocco 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
BE - Belgio 6
CO - Colombia 6
LT - Lituania 6
HR - Croazia 5
NG - Nigeria 5
VE - Venezuela 5
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
GT - Guatemala 3
JM - Giamaica 3
PE - Perù 3
PT - Portogallo 3
AM - Armenia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CL - Cile 1
CU - Cuba 1
GE - Georgia 1
JE - Jersey 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
RS - Serbia 1
SI - Slovenia 1
TJ - Tagikistan 1
Totale 14.500
Salva come PNG Salva come JPEG
Città #
Singapore 990
Bologna 745
Ashburn 589
Southend 415
Chandler 354
Fairfield 324
Hefei 323
Hong Kong 275
Ho Chi Minh City 267
Hanoi 253
San Jose 243
Houston 236
Seattle 178
Santa Clara 176
Woodbridge 162
Dublin 139
Seoul 137
Wilmington 135
Boardman 134
Milan 125
Cambridge 122
Beijing 121
Princeton 117
Dallas 104
Vienna 100
Council Bluffs 91
Abidjan 89
Lauterbourg 89
Dong Ket 79
Helsinki 77
Ann Arbor 75
New York 74
Los Angeles 73
São Paulo 73
Tokyo 72
Redmond 62
Bremen 58
Nanjing 58
Lomé 56
Rome 48
Westminster 46
Amman 45
Berlin 43
Buffalo 42
Da Nang 41
Sofia 40
Munich 39
Naples 39
Frankfurt am Main 38
Haiphong 38
Modena 37
Amsterdam 36
Jakarta 36
Shanghai 35
Padova 34
Bengaluru 31
London 29
Florence 27
Guangzhou 26
Nuremberg 26
Bern 25
Jinan 25
Saint Petersburg 25
Redondo Beach 24
Shenyang 24
Chicago 23
Turin 23
Rimini 22
Orem 21
Medford 20
The Dalles 20
Lappeenranta 18
San Diego 18
Bangkok 17
Jiaxing 17
Montreal 17
Changsha 16
Hải Dương 16
Jacksonville 16
Reggio Emilia 16
Boydton 15
Can Tho 15
Falkenstein 15
San Francisco 15
Turku 15
Zhengzhou 15
Tianjin 14
Toronto 14
Düsseldorf 13
Forlì 13
Kuala Lumpur 13
Olalla 13
Rehovot 13
Thái Nguyên 13
Xi'an 13
Brescia 12
Phoenix 12
Warsaw 12
Atlanta 11
Dearborn 11
Totale 9.236
Salva come PNG Salva come JPEG
Nome #
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration 414
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 312
EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer 276
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 268
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects 253
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer 238
Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate 238
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 236
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 228
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 227
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 224
A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. 221
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 220
Submicroscopic alterations and gene expression profiles of human colon cancer cell lines in response to cetuximab, gefitinib and EGF 220
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 217
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 216
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 214
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 211
Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood 210
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection 208
The EGFR R521K polymorphism influences the risk to develop colorectal cancer. 207
Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. 206
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 204
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 203
Modulation of ERBB signaling from tissue homeostasis to cancer progression 201
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 201
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 199
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. 198
Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant. 196
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 196
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 189
ERBB2 circumvents negative feedback mechanisms induced by EGFR overactivation in basal-like/triple-negative breast cancer cells 188
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 188
The roadmap of colorectal cancer screening 187
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 186
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection 182
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 176
Estrogen Receptors and Melanoma: A Review 173
Fibroblast-associated protein-α expression and BPV nucleic acid distribution in equine sarcoids 173
A putative role for interleukin 1 pathway in resistance to EGFR blockade 171
Resistance to EGFR Targeting Treatments in Colorectal Cancer 167
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer 166
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 166
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 166
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor 162
The R521K polymorphism of EGFR influences the risk of colorectal cancer 161
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 161
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors 155
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 146
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 143
Identification of novel growth factors for cardiac regeneration 142
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 138
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 138
qCMA: A Desktop Application for Quantitative Collective Cell Migration Analysis 136
null 136
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 135
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study 135
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 134
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade 132
null 128
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 123
A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib 122
null 121
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 117
null 117
Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals 115
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 114
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions 113
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 110
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling 110
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 104
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. 104
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result 102
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation 100
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 96
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 95
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 94
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers 92
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 90
null 87
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer 87
Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes 86
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers 84
null 82
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 81
null 81
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 77
null 74
null 72
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy 65
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 64
Circadian dependent motility: the role for the perinuclear actin cap 57
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression 56
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 47
Harnessing glucocorticoid receptor antagonism to enhance the efficacy of cardiac regenerative growth factors and cytokines 45
Sorcin regulates alveolarization and airway tissue remodeling during lung morphogenesis 42
Towards the emerging crosstalk: ERBB family and steroid hormones 31
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy 14
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies 12
Totale 14.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021211 0 0 0 0 0 0 0 0 0 0 0 211
2021/20221.144 71 38 60 57 88 64 32 81 74 81 250 248
2022/20231.788 142 220 101 253 147 135 79 130 306 49 105 121
2023/2024752 59 93 40 75 60 144 40 46 25 75 41 54
2024/20252.582 104 235 225 181 281 147 295 143 85 209 235 442
2025/20266.036 469 584 526 428 516 367 625 198 1.215 490 318 300
Totale 14.905